Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Combination Olanzapine and Lithium and Combination Chlorpromazine and Lithium in the Treatment of a First Manic Episode With Psychotic Features.

NCT00202293 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT00202293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00202293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Combination Olanzapine and Lithium and Combination Chlorpromazine and Lithium in the Treatment of a First Manic Episode With Psychotic Features.
Lead sponsor
Melbourne Health
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2001
Completion date
November 1, 2015
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, schizoaffective disorder